Neuberger Berman Group’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-177,000
| Closed | -$3.09M | – | 1857 |
|
|
2020
Q4 | $3.09M | Hold |
177,000
| – | – | ﹤0.01% | 1026 |
|
|
2020
Q3 | $2.07M | Hold |
177,000
| – | – | ﹤0.01% | 1054 |
|
|
2020
Q2 | $2.3M | Hold |
177,000
| – | – | ﹤0.01% | 981 |
|
|
2020
Q1 | $1.64M | Buy |
177,000
+42,000
| +31% | +$587K | ﹤0.01% | 992 |
|
|
2019
Q4 | $2.24M | Sell |
135,000
-8,200
| -6% | -$133K | ﹤0.01% | 1010 |
|
|
2019
Q3 | $2.38M | Buy |
143,200
+15,100
| +12% | +$209K | ﹤0.01% | 977 |
|
|
2019
Q2 | $1.76M | Buy |
128,100
+48,100
| +60% | +$736K | ﹤0.01% | 1058 |
|
|
2019
Q1 | $1.38M | Hold |
80,000
| – | – | ﹤0.01% | 1049 |
|
|
2018
Q4 | $1.02M | Hold |
80,000
| – | – | ﹤0.01% | 1116 |
|
|
2018
Q3 | $1.3M | Buy |
+80,000
| New | +$1.14M | ﹤0.01% | 1137 |
|
|
2018
Q1 | – | Sell |
-99,106
| Closed | -$1.39M | – | 1779 |
|
|
2017
Q4 | $1.39M | Buy |
99,106
+21,849
| +28% | +$320K | ﹤0.01% | 1109 |
|
|
2017
Q3 | $1.3M | Sell |
77,257
-27,000
| -26% | -$439K | ﹤0.01% | 1086 |
|
|
2017
Q2 | $1.75M | Sell |
104,257
-29,972
| -22% | -$448K | ﹤0.01% | 1029 |
|
|
2017
Q1 | $2.08M | Buy |
134,229
+79,129
| +144% | +$1.13M | ﹤0.01% | 998 |
|
|
2016
Q4 | $824K | Sell |
55,100
-1,791
| -3% | -$25.1K | ﹤0.01% | 1183 |
|
|
2016
Q3 | $715K | Buy |
+56,891
| New | +$571K | ﹤0.01% | 1182 |
|
Neuberger Berman Group's OXFD Position: Q1 2021 in Review
Neuberger Berman Group sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q1 2021, closing a stake of 177,000 shares — an estimated $3.09M sold.
Neuberger Berman Group first reported a position in OXFD in Q3 2016 and held it in 16 quarters. The position peaked at $3.09M in Q4 2020. 0 funds tracked by Wall St. Rank hold OXFD as of Q1 2021.
- Neuberger Berman Group reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q1 2021 after selling out during the quarter.
- Neuberger Berman Group sold 177,000 Oxford Immunotec Global PLC Ordinary Shares shares in Q1 2021, an estimated $3.09M.
- Neuberger Berman Group first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q3 2016 and held it in 16 quarters.
- Neuberger Berman Group's Oxford Immunotec Global PLC Ordinary Shares position peaked at $3.09M in Q4 2020.
- 0 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q1 2021.
Based on Neuberger Berman Group's 13F filing for Q1 2021, filed 13 May 2021.